(S)-1-(Pyrrolidin-3-yl)piperidine dihydrochloride

Catalog No. :
ACSXQH548
CAS No. :
917505-12-5
Molecular Formula :
C9H20Cl2N2
Molecular Weight :
227.18

IUPAC Name:(S)-1-(pyrrolidin-3-yl)piperidine dihydrochloride

(S)-1-(Pyrrolidin-3-yl)piperidine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$54.00Login to see priceIn stockIn stock
1g95%$89.00Login to see priceIn stockIn stock
5g95%$355.00Login to see priceIn stockIn stock
25g95%$1740.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-1-(Pyrrolidin-3-yl)piperidine dihydrochloride
IUPAC Name(S)-1-(pyrrolidin-3-yl)piperidine dihydrochloride
MDL No.MFCD11849811
Molecular FormulaC9H20Cl2N2
Molecular Weight227.18
SMILES[H]Cl.[H]Cl.N1([C@@H]2CNCC2)CCCCC1
InChI KeyGDPYVOIPMPHKGB-WWPIYYJJSA-N
Synonym1-[(3S)-3-PYRROLIDINYL]-PIPERIDINE DIHYDROCHLORIDE;Piperidine, 1-[(3S)-3-pyrrolidinyl]-, hydrochloride (1:2);1-[(3S)-3-PYRROLIDINYL]-PIPERIDINE 2HCL;(S)-1-(pyrrolidin-3-yl)piperidine dihydrochloride;1-((S)-pyrrolidin-3-yl)piperidine 2HCl;(S)-1-(3-Pyrrolidinyl)piperidine Dihydrochloride;(S)-1-(Pyrrolidin-3-yl)piperidine dihydrochloride - [P91446]
CAS No.917505-12-5
PubChem CID71464052

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSXQH548 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSXQH548 route product structure diagram
    ACSXQH548917505-12-5 In Stock
Inquiry

2. ACSXQH548 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSXQH548 route product structure diagram
    ACSXQH548917505-12-5 In Stock
Inquiry

Comments (0)